Tirzepatide received FDA approval for chronic weight management in adults with obesity or overweight with weight-related health conditions under the brand name Zepbound in November 2023
The package is available at Ritual Aesthetics Clinic, First Floor, Bakeman Plaza, Markaz, F-8, Islamabad
A recent study had shown that fecal bacteria such as Actinobacteria , Bifidobacterium , and Faecalibacterium prausnitzii , in patients on a low FODMAPs diet were reduced significantly along with reduction in pro-inflammatory cytokines (Hustoft et al., 2017)
Branded Drug Context: Ozempic, Wegovy, Mounjaro, Zepbound Ozempic and Wegovy contain semaglutide
It is currently in Phase 3 clinical trials globally